MedPath

A study to compare two types of therapy in locally advanced gall bladder cancer: Chemotherapy combined with irreversible electroporation versus chemotherapy alone

Not Applicable
Conditions
Health Condition 1: C23- Malignant neoplasm of gallbladder
Registration Number
CTRI/2021/05/033803
Lead Sponsor
SERB
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients with unresectable malignant GB masses

2. Life expectancy of at least 3 months.

3. Size of tumor < 6 cm in largest dimension.

4. Total bilirubin level < 2.5 mg/dl

Exclusion Criteria

1. Uncorrectable coagulopathy

2. Patients with poor general condition and estimated life expectancy less than 3

months

3. Patients unfit for general anaesthesia

4. Presence of cardiac disease/arrhythmia/heart block

5. Presence of malignant ascites

6. Presence of metastatic disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
SurvivalTimepoint: One year
Secondary Outcome Measures
NameTimeMethod
Safety of the procedure <br/ ><br>Quality of lifeTimepoint: Safety of the procedure-baseline <br/ ><br>Quality of life-baseline and at 4 weeks <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath